U.S. Health Secretary Robert F. Kennedy Jr.'s recent dismissal of all 17 members of the CDC's Advisory Committee on Immunization Practices (ACIP) has triggered a strong backlash from vaccine experts. The ousted panelists warn that the abrupt shakeup may undermine public health, reduce access to lifesaving vaccines, and increase the risk of preventable disease outbreaks.
Kennedy, a longtime vaccine skeptic, replaced the committee with eight new appointees, some of whom have publicly questioned vaccine safety. The decision was made just two days after the firings on June 9, 2025. In a joint article published in the Journal of the American Medical Association (JAMA), the former ACIP members expressed alarm over what they described as a destabilizing and unjustified overhaul.
They argue that the move, along with cuts to CDC immunization staff, weakens the national vaccine program and threatens decades of progress. “These decisions, made without clear rationale, may roll back the achievements of U.S. immunization policy,” the experts wrote. They emphasized the potential risk to public trust and the safety of families across the country.
Kennedy claimed the firings were necessary to eliminate alleged conflicts of interest among the previous panel members, many of whom were appointed during the Biden administration. However, he provided no evidence of specific misconduct or bias.
Health professionals and scientists warn that politicizing vaccine oversight could erode confidence in health authorities and negatively impact vaccine uptake. The Department of Health and Human Services has not yet responded to media inquiries regarding the controversy.
Kennedy’s sweeping changes mark a significant shift in U.S. health policy and come amid growing concerns over misinformation and vaccine hesitancy.


RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
TikTok Nears $400 Million Settlement With Trump Administration Over Child Privacy Lawsuit
White House Withdraws Trump’s National Park Service Nominee Amid Criticism
Google Secures Pentagon AI Deal for Classified Projects
U.S., South Korea Launch Shipbuilding Partnership Initiative
Mexico President Claudia Sheinbaum Reconsiders Early School Closure Plan Ahead of 2026 World Cup
Trump Administration Releases New UFO Files and Apollo Mission Records
U.S.-China Beef Trade Deal Hopes Rise Ahead of Trump-Xi Summit
Trump Invites Top CEOs Including Nvidia, Apple, Boeing to China Summit With Xi Jinping
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Judge Delays SEC Settlement With Elon Musk Over Twitter Stock Disclosure Case
U.S. Fast-Tracks $8.6 Billion Arms Sales to Middle East Allies Amid Rising Tensions
Panama Defends Port Takeover Amid U.S.-China Tensions and Canal Dispute
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology 



